Cure My Disease

Don't miss your cure!

 Log in / Sign up

3D-Printed tooth fillings could offer kids a better option for weak molars

NCT ID NCT07718191

Not yet recruiting Disease control Sponsor: Cairo University Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests whether 3D-printed hybrid resin fillings work better than standard composite fillings for children aged 7 to 11 who have a condition called molar-incisor hypomineralization (MIH), which causes weak, chalky molars. The trial measures pain before and after treatment and checks how well the fillings hold up over 6 and 12 months. Forty children will receive either a 3D-printed or a direct filling to see which approach leads to better outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
3D-printed hybrid resin restoration or direct resin composite filling
What this could lead to
If successful, 3D-printed fillings could offer a more durable and comfortable option for treating children with weak, chalky molars.
What could go wrong
This is a small, early-stage trial with only 40 participants, so results may not apply to all children. The 3D-printed fillings may not outperform standard fillings in the long run.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MOLAR-INCISOR HYPOMINERALIZATION (MIH) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Molar Hypomineralization

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MOLAR-INCISOR HYPOMINERALIZATION (MIH)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.